The investigation determined an (b)(6) anti-hav igm result was obtained from a quality control sample as part of internal post expiry stability testing, using a vitros eci immunodiagnostic system.A definitive assignable cause could not be determined.Repeat testing using the same in-house quality control material and reagent lot fell within the expected release limits.It is not known whether the vitros systems were operating as expected at the time of the events as no performance testing was undertaken.
|